Search Results

There are 6268 results for: content related to: The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

  1. Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis

    The Journal of Clinical Pharmacology

    Volume 47, Issue 12, December 2007, Pages: 1466–1475, Nianhang Chen, Henry Lau, Linghui Kong, Gondi Kumar, Jerom B. Zeldis, Robert Knight and Osca L. Laskin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007309563

  2. You have free access to this content
    Lenalidomide downregulates the cell survival factor, interferon regulatory factor-4, providing a potential mechanistic link for predicting response

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 325–336, Antonia Lopez-Girona, Daniel Heintel, Ling-Hua Zhang, Derek Mendy, Svetlana Gaidarova, Helen Brady, Justin Blake Bartlett, Peter H. Schafer, Martin Schreder, Arnold Bolomsky, Bernadette Hilgarth, Niklas Zojer, Heinz Gisslinger, Heinz Ludwig, Tom Daniel, Ulrich Jäger and Rajesh Chopra

    Version of Record online : 24 JUN 2011, DOI: 10.1111/j.1365-2141.2011.08689.x

  3. You have free access to this content
    Lenalidomide in multiple myeloma: Current status and future potential

    American Journal of Hematology

    Volume 87, Issue 12, December 2012, Pages: 1089–1095, Hang Quach, Anna Kalff and Andrew Spencer

    Version of Record online : 28 MAY 2012, DOI: 10.1002/ajh.23234

  4. Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 650–660, Dr William L. Dahut, Dr Jeanny B. Aragon-Ching, Dr Sukyung Woo, Dr Tanyifor M. Tohnya, Dr James L. Gulley, Dr Philip M. Arlen, Dr John J. Wright, Dr Jurgen Ventiz and Dr William D. Figg

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009335001

  5. Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

    European Journal of Haematology

    Volume 85, Issue 3, September 2010, Pages: 200–208, Francesca Gay, S. Vincent Rajkumar, Patrizia Falco, Shaji Kumar, Angela Dispenzieri, Maria Teresa Petrucci, Morie A. Gertz, Mario Boccadoro, A. Keith Stewart and Antonio Palumbo

    Version of Record online : 8 MAY 2010, DOI: 10.1111/j.1600-0609.2010.01469.x

  6. You have free access to this content
    Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients

    Clinical & Experimental Immunology

    Volume 177, Issue 2, August 2014, Pages: 439–453, A. Busch, D. Zeh, V. Janzen, L.-O. Mügge, D. Wolf, L. Fingerhut, C. Hahn-Ast, O. Maurer, P. Brossart and M. von Lilienfeld-Toal

    Version of Record online : 9 JUL 2014, DOI: 10.1111/cei.12343

  7. Distribution of Lenalidomide Into Semen of Healthy Men After Multiple Oral Doses

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 767–774, Nianhang Chen, Henry Lau, Somesh Choudhury, Xiaomin Wang, Mahmoud Assaf and Oscar L. Laskin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009355157

  8. You have free access to this content
    Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review

    American Journal of Hematology

    Volume 86, Issue 6, June 2011, Pages: 467–470, M. Kathleen Figaro, Warren Clayton Jr., Chinenye Usoh, Kara Brown, Adetola Kassim, Vipul T. Lakhani and Shubhada Jagasia

    Version of Record online : 4 MAY 2011, DOI: 10.1002/ajh.22008

  9. A review of the history, properties, and use of the immunomodulatory compound lenalidomide

    Annals of the New York Academy of Sciences

    Volume 1222, Issue 1, March 2011, Pages: 76–82, Jerome B. Zeldis, Robert Knight, Mohamad Hussein, Rajesh Chopra and George Muller

    Version of Record online : 22 MAR 2011, DOI: 10.1111/j.1749-6632.2011.05974.x

  10. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 856–867, J.Y. Henry, L. Lu, M. Adams, B. Meyer, J.B. Bartlett, Prof. A.G. Dalgleish and C. Galustian

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pros.21488

  11. You have full text access to this OnlineOpen article
    Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma

    European Journal of Haematology

    Volume 82, Issue 6, June 2009, Pages: 426–432, Edward A. Stadtmauer, Donna M. Weber, Ruben Niesvizky, Andrew Belch, Miles H. Prince, Jesús F. San Miguel, Thierry Facon, Marta Olesnyckyj, Zhinuan Yu, Jerome B. Zeldis, Robert D. Knight and Meletios A. Dimopoulos

    Version of Record online : 19 MAR 2009, DOI: 10.1111/j.1600-0609.2009.01257.x

  12. You have free access to this content
    Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression

    British Journal of Haematology

    Volume 160, Issue 4, February 2013, Pages: 487–502, Ling-Hua Zhang, Jolanta Kosek, Maria Wang, Carla Heise, Peter H. Schafer and Rajesh Chopra

    Version of Record online : 18 DEC 2012, DOI: 10.1111/bjh.12172

  13. You have free access to this content
    Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

    British Journal of Haematology

    Volume 166, Issue 2, July 2014, Pages: 189–201, Joaquín Sánchez-García, Consuelo del Cañizo, Ignacio Lorenzo, Benet Nomdedeu, Elisa Luño, Raquel de Paz, Blanca Xicoy, David Valcárcel, Salut Brunet, Victor Marco-Betes, Marta García-Pintos, Santiago Osorio, Mar Tormo, Alicia Bailén, Carlos Cerveró, Fernando Ramos, María Diez-Campelo, Esperanza Such, Beatriz Arrizabalaga, Gemma Azaceta, Joan Bargay, María J. Arilla, José Falantes, Josefina Serrano-López, Guillermo F. Sanz and forthe Spanish Group on Myelodysplastic Syndromes (GES MD)

    Version of Record online : 9 APR 2014, DOI: 10.1111/bjh.12876

  14. You have free access to this content
    Short-Term Lenalidomide (Revlimid) Administration Ameliorates Cardiomyocyte Contractile Dysfunction in ob/ob Obese Mice


    Volume 20, Issue 11, November 2012, Pages: 2174–2185, Linlin Li, Yinan Hua, Maolong Dong, Quan Li, Derek T. Smith, Ming Yuan, Kyla R. Jones and Jun Ren

    Version of Record online : 31 DEC 2012, DOI: 10.1038/oby.2012.106

  15. Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels

    European Journal of Haematology

    Volume 91, Issue 6, December 2013, Pages: 504–513, Alexandra J. Greenberg, Denise K. Walters, Shaji K. Kumar, S. Vincent Rajkumar and Diane F. Jelinek

    Version of Record online : 17 SEP 2013, DOI: 10.1111/ejh.12192

  16. You have free access to this content
    Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 327–333, Kami Maddocks, Lai Wei, Darlene Rozewski, Yao Jiang, Yuan Zhao, Mikhil Adusumilli, William E. Pierceall, Camille Doykin, Michael H. Cardone, Jeffrey A. Jones, Joseph Flynn, Leslie A. Andritsos, Michael R. Grever, John C. Byrd, Amy J. Johnson, Mitch A. Phelps and Kristie A Blum

    Version of Record online : 25 FEB 2015, DOI: 10.1002/ajh.23946

  17. You have free access to this content
    Lenalidomide is safe and active in Waldenström macroglobulinemia

    American Journal of Hematology

    Volume 90, Issue 11, November 2015, Pages: 1055–1059, Guillemette Fouquet, Stéphanie Guidez, Marie-Odile Petillon, Chanaz Louni, Bella Ohyba, Malek Dib, Stéphanie Poulain, Charles Herbaux, Audrey Martin, Béatrice Thielemans, Pauline Brice, Sylvain Choquet, Jana Bakala, Claire Bories, Hélène Demarquette, Morgane Nudel, Olivier Tournilhac, Bertrand Arnulf, Steven LeGouill, Pierre Morel, Anne Banos, Lionel Karlin, Gilles Salles, Véronique Leblond and Xavier Leleu

    Version of Record online : 6 OCT 2015, DOI: 10.1002/ajh.24175

  18. You have free access to this content
    Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response

    British Journal of Haematology

    Volume 155, Issue 4, November 2011, Pages: 457–467, Asher A. Chanan-Khan, Kasyapa Chitta, Noreen Ersing, Aneel Paulus, Aisha Masood, Taimur Sher, Abhisek Swaika, Paul K. Wallace, Terry L. Mashtare Jr, Greg Wilding, Kelvin Lee, Myron S. Czuczman, Ivan Borrello and Naveen Bangia

    Version of Record online : 20 OCT 2011, DOI: 10.1111/j.1365-2141.2011.08882.x

  19. The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib

    European Journal of Haematology

    Volume 88, Issue 5, May 2012, Pages: 446–449, Paul G. Richardson, Jacob P. Laubach, Robert L. Schlossman, Irene M. Ghobrial, Katherine C. Redman, Mary Mckenney, Diane Warren, Kimberly Noonan, Laura Lunde, Deborah Doss, Kathleen Colson, Teru Hideshima, Constantine Mitsiades, Nikhil C. Munshi and Kenneth C. Anderson

    Version of Record online : 7 MAR 2012, DOI: 10.1111/j.1600-0609.2012.01765.x

  20. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome

    European Journal of Haematology

    Volume 95, Issue 4, October 2015, Pages: 325–330, Qian-Qian Cai, Chen Wang, Xin-Xin Cao, Hao Cai, Dao-Bin Zhou and Jian Li

    Version of Record online : 10 FEB 2015, DOI: 10.1111/ejh.12492